These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6820857)

  • 21. [Critical considerations on the question of "masked macrophages" in cerebrospinal fluid cell sediment].
    Hackenberg P
    Dtsch Z Nervenheilkd; 1967; 192(2):124-38. PubMed ID: 4169217
    [No Abstract]   [Full Text] [Related]  

  • 22. [Differences in the electrophoretic pictures of the cerebrospinal fluid proteins in suppurative and lymphocytic meningitis in children].
    Zoch-Zwierz W; Rudobielska M; Kossakowski R
    Pediatr Pol; 1982 Nov; 57(11):937-43. PubMed ID: 7170119
    [No Abstract]   [Full Text] [Related]  

  • 23. [Introduction and application of CSF cytology for diagnosis and treatment of central nervous system diseases].
    Su XC; Zhao G; Yang YN; Deng YC
    Acta Neurol Taiwan; 2006 Jun; 15(2):143-8. PubMed ID: 16871902
    [No Abstract]   [Full Text] [Related]  

  • 24. Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparations: is it of clinical importance?
    Berntorp E
    Haematologica; 2003 Jun; 88(6):EREP03. PubMed ID: 12826529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytology of the cerebrospinal fluid].
    Dietrichson P
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2121. PubMed ID: 4773987
    [No Abstract]   [Full Text] [Related]  

  • 26. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
    Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune tolerance induction with high von Willebrand factor/factor VIII content ratio concentrate in children with haemophilia A and high-responding inhibitor.
    Platokouki H; Pergantou H; Xafaki P; Komitopoulou A; Aronis S
    Haemophilia; 2009 Mar; 15(2):617-9. PubMed ID: 19175417
    [No Abstract]   [Full Text] [Related]  

  • 28. Mollaret's meningitis: case report with immunocytochemical and polymerase chain reaction amplification studies.
    Teot LA; Sexton CW
    Diagn Cytopathol; 1996 Nov; 15(4):345-8. PubMed ID: 8982594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. von Willebrand factor as a regulator of intrinsic factor X activation.
    Koppelman SJ; Koedam JA; van Wijnen M; Stern DM; Nawroth PP; Sixma JJ; Bouma BN
    J Lab Clin Med; 1994 Apr; 123(4):585-93. PubMed ID: 8145007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of monoclonally-purified and recombinant factor VIII in patients with severe von Willebrand disease.
    Morfini M; Mannucci PM; Tenconi PM; Longo G; Mazzucconi MG; Rodeghiero F; Ciavarella N; De Rosa V; Arter A
    Thromb Haemost; 1993 Aug; 70(2):270-2. PubMed ID: 8236134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ticlopidine and dexamethasone on fibronectin and factor VIII-related antigen synthesis by cultured endothelial cells.
    Piovella F; Giddings JC; Almasio P; Ricetti MM; Thomas JE
    Thromb Res Suppl; 1983; 4():69-73. PubMed ID: 6415859
    [No Abstract]   [Full Text] [Related]  

  • 33. [Acquired autoantibodies against human factor VIII: a new case].
    Cailleux N; Levesque H; Courtois H; Borg JY
    J Mal Vasc; 1996; 21(5):324-8. PubMed ID: 9026552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII.
    Rick ME; Krizek DM
    Am J Hematol; 1996 Apr; 51(4):302-6. PubMed ID: 8602631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of factor VIII-related antigen and Ulex lectin binding sites in endothelial cells during long-term culture.
    Hormia M
    Cell Biol Int Rep; 1982 Dec; 6(12):1123-34. PubMed ID: 6817927
    [No Abstract]   [Full Text] [Related]  

  • 36. Cerebrospinal fluid electrolyte disturbances in neurological disorders: with special reference to inorganic phosphate.
    Breyer U; Kanig K
    Neurology; 1970 Mar; 20(3):247-53. PubMed ID: 5461053
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods.
    Rodgers SE; Lerda NV; Favaloro EJ; Duncan EM; Casey GJ; Quinn DM; Hertzberg M; Lloyd JV
    Am J Clin Pathol; 2002 Aug; 118(2):269-76. PubMed ID: 12162689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acquired von Willebranol syndrome--its pathophysiology, diagnosis and treatment].
    Mohri H
    Rinsho Ketsueki; 2001 Jul; 42(7):525-36. PubMed ID: 11524842
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunogenicity and immune tolerance coagulation Factors VIII and IX.
    Rup B
    Dev Biol (Basel); 2003; 112():55-9. PubMed ID: 12762504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid concentration of fibronectin in meningitis.
    Torre D; Zeroli C; Issi M; Fiori GP; Ferraro G; Speranza F
    J Clin Pathol; 1991 Sep; 44(9):783-4. PubMed ID: 1918413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.